AUG 04, 2019 4:41 PM PDT

New Research In Reversing Deafness

WRITTEN BY: Amanda Mikyska

Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate if damaged.  In humans, when a hair cell dies because of damage from loud noises, a virus, or genetic mutation, the loss is permanent.    

Scientists at Johns Hopkins University are now investigating the molecular signaling pathways of hair cell differentiation and growth, to find a way to regenerate damaged hair cells.  This would help people with deafness regain hearing, regardless of the cause.

Undamaged cochlear hair cells vs. damaged cochlear hair cells.

 

Previously, scientist knew about two genes, HEY1 and HEY2, which repress the differentiation of precursor hair cells into functional hair cells.  Without the HEY1 and HEY2 genes, cells prematurally differentiate and do not fully grow.  Interestingly, the expression of these two genes also expresses small amounts of "inhibitor of differentiation" (ID) proteins.  An accumulation of ID proteins, however, interfere with the ability of repressors to bind to the DNA.  When the repressor proteins cannot bind to DNA, the cells differentiate into audio-sensing hair cells, in an organized spiral.  The slow accumulation of ID proteins is a biological timer that results in the precise birth of audio-sensing cells.  

Most recently, scientists at Johns Hopkins University found that the proteins responsible for balancing the timing of differentiation are Activin A, a member of the cytokinin family, and  Follistatin (FST).  Precursor hair cells grow from the outside of the cochlear spiral to the inside.  Along the way, FST is expressed and represses differentiation of these precursor hair cells.  Activin A signals differentiation and is expressed in the reverse direction, beginning with cells at the center of the cochlear spiral.   

At the moment, there is no way to engineer hair cells to regenerate.  However, with more research on the underlying molecular controls, a therapy for hearing loss draws closer.   
 

 

Sources: Prajapati-DiNubila

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
AUG 19, 2020
Cell & Molecular Biology
Mild COVID-19 Cases Induce an Immune Cell Response
AUG 19, 2020
Mild COVID-19 Cases Induce an Immune Cell Response
As the pandemic virus, SARS-CoV-2 continues to cause tens of thousands of new cases of COVID-19 every day in the United ...
OCT 05, 2020
Immunology
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
OCT 05, 2020
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
  Australian scientists have zeroed in on a gene linked to an increased obesity risk: a regulator of inflammation c ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 25, 2020
Immunology
Another COVID-19 vaccine shows promising results!
NOV 25, 2020
Another COVID-19 vaccine shows promising results!
A week ago, another biotechnology company "Moderna" announced the preliminary results from its COVID-19 vaccin ...
Loading Comments...